Neuroscience Team Recognized as Unit of Distinction

Translate to Spanish or other 102 languages!

Colleagues from RGRH’s Critical Care - Progressive Care Unit, Recipient of HCA Healthcare’s the Neuroscience Unit of Distinction. Courtesy Photo RGRH
Colleagues from RGRH’s Critical Care – Progressive Care Unit, Recipient of HCA Healthcare’s the Neuroscience Unit of Distinction. Courtesy Photo RGRH

Mega Doctor News

- Advertisement -

McALLEN, Texas – Rio Grande Regional Hospital (RGRH) is proud and excited to announce that the Neuroscience team was recently recognized as a Recipient of the HCA Healthcare Critical Care – Progressive Care Unit of Distinction.  A total of 202 nursing units from across the country were recognized as top-performing nursing units. 

Units of Distinction are categorized in the top five percent of all HCA Healthcare medical-surgical, critical care, emergency services, surgical services, behavioral health, women’s and children’s nursing units, pediatrics/PICU, and inpatient rehabilitation units.  The top six to 10  percent of all HCA Healthcare units earned honorable mention designations. Our quality of care includes a multidisciplinary approach that consists of emergency room physicians, vascular-trained neurologists available 24-7, neurosurgeons, cardiologists, and an excellent rehabilitation team. 

Congratulations to the Neuroscience team for raising the bar and for their continued commitment to our mission, “Above all else, we are committed to the care and improvement of human life.”  

- Advertisement -

To learn more about the Stroke and Neurosciences programs, visit RioHealth.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.

STHS & Prominence Health Hosting “Senior Living Seminar” on Malnutrition, Sept. 4th

Malnutrition is often an invisible health concern, quietly undermining an older adult's strength, independence and overall quality of life. Yet its warning signs are frequently overlooked or mistaken for a normal part of aging.
- Advertisement -